ClinicalTrials.Veeva

Menu

Cognitive Reserve and Second Language Acquisition

R

Rotman Research Institute at Baycrest

Status

Unknown

Conditions

Executive Function

Treatments

Behavioral: Duolingo
Behavioral: BrainHQ
Behavioral: Passive Control

Study type

Interventional

Funder types

Other

Identifiers

NCT03638882
I2P2-2-00140

Details and patient eligibility

About

Bilingualism has been shown to have a strong protective effect against dementia, delaying the diagnosis of Alzheimer's disease by up to 4 years. The purpose of the study is to test whether learning a second language using Duolingo software could improve cognitive functions in older adults.

Full description

This study is a 3-arm, randomized controlled trial. The primary objective of the study is to test the impact of second language acquisition through short-term use of the Duolingo app on cognitive functioning, particularly executive function in older adults compared to a brain training application.

Enrollment

90 estimated patients

Sex

All

Ages

65 to 75 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Participants must have normal vision and hearing.
  • Participants must be able to travel to Baycrest by personal or study-arranged automobile, or public transportation.
  • Participants must be monolingual native English speakers.
  • Participants must be willing to provide informed consent.
  • Participants must have daily access to a smartphone/mobile device.
  • Have not previously studied Spanish formally, nor any other language in the past 10 years.

Exclusion criteria

  • have a neurological disorder.
  • meet DSM-IV-TR criteria for Axis I mood, anxiety, or psychotic or substance abuse disorders.
  • Fluent in more than one language.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

90 participants in 3 patient groups, including a placebo group

Duolingo Spanish Course
Experimental group
Description:
30 minutes each day, 5 days a week for 16 weeks. Total of 40 hours.
Treatment:
Behavioral: Duolingo
BrainHQ
Active Comparator group
Description:
30 minutes each day, 5 days a week for 16 weeks. Total of 40 hours.
Treatment:
Behavioral: BrainHQ
Passive Control
Placebo Comparator group
Description:
No intervention.
Treatment:
Behavioral: Passive Control

Trial contacts and locations

1

Loading...

Central trial contact

Jed Meltzer, Ph.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems